University of California Health Cancer Clinical Trials, By Type
- Abdominal Neoplasm
- Abiraterone Acetate
- Abnormal DNA Repair
- Acinar Cell Carcinoma
- Acoustic Neuroma
- Acquired Resistance to KRAS G12C Inhibitor
- Actinic Keratosis
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Acute Promyelocytic Leukemia
- Adenocarcinoma
- Adenocarcinoma of the Lung
- Adenocarcinoma of the Rectum
- Adenoid Cystic Carcinoma
- Adrenal Gland Neoplasm
- Adrenocortical Carcinoma
- Advanced/Metastatic Cancer
- Advanced Systemic Mastocytosis
- Aggressive Systemic Mastocytosis
- AL Amyloidosis
- ALK Positive
- Ampullary Cancer
- Anal Basaloid Carcinoma
- Anal Canal Cloacogenic Carcinoma
- Anal Canal Undifferentiated Carcinoma
- Anal Cancer
- Anal HSIL
- Anaplastic Ganglioglioma
- Anaplastic Oligodendroglioma
- Anaplastic Pleomorphic Xanthoastrocytoma
- Androgen Deprivation Therapy
- Angiosarcoma
- Anogenital Cancers
- Antineoplastic Agents
- Antineoplastic Agents, Hormonal
- Antineoplastics Toxicity
- Apocrine Carcinoma
- Apocrine Neoplasm
- Appendiceal Mucinous Neoplasm
- Appendix Cancer
- ARID1A Gene Mutation
- Astroblastoma
- Astrocytoma
- ASXL1 Gene Mutation
- ASXL2 Gene Mutation
- ATM Gene Mutation
- B-Cell Acute Lymphoblastic Leukemia
- B-cell Malignancy
- Barrett's Esophagus
- Basal Cell Carcinoma
- Biliary Tract Cancer
- Bladder Cancer
- Blastic Plasmacytoid Dendritic Cell Neoplasm
- Blood Cancer
- Bone Cancer
- Bone, Metastatic Cancer
- Bone Tumor
- Borderline Ovarian Mucinous Tumor
- BRAF
- BRAF Gene Mutation
- BRAF Mutation-Related Tumors
- BRAF V600 Mutation
- BRAF V600E
- BRAF V600E Mutation Present
- Brain and Central Nervous System Tumor
- Brain Cancer
- Brain Tumor
- BRCA 1 Gene Mutation
- BRCA 2 Gene Mutation
- BRCA Gene Rearrangement
- BRCA Mutation
- Breast Cancer
- Breast Inflammatory Carcinoma
- Breast Lobular Carcinoma In Situ
- Breast Metaplastic Carcinoma
- Breast Tumor
- BRIP1 Mutation
- Cancer Cachexia
- Cancer, General
- Cancer Harboring BRAF Alterations
- Cancer of Unknown Primary Site
- Cancer Pain
- Cancer Predisposition Syndrome
- Cancer Prevention
- Cancer Risk
- Cancer Weight Loss
- CAR T-Cell Therapy
- Carcinoid Tumor
- Carcinoma
- Carcinoma Arising From Cylindroma
- Carcinoma Arising From Spiradenoma
- Carcinoma, Ductal, Breast
- Carcinoma in Situ
- Carcinoma, Intraductal, Noninfiltrating
- Carcinoma of Unknown Primary
- Carcinoma, Renal Cell, Advanced
- Carcinoma, Renal Cell Metastasis
- Castleman Disease
- Castration Levels of Testosterone
- CCNE1 Amplification
- CD19 Positive
- CD20 Positive
- CDK Gene Mutation
- CDK4/6 Inhibitors
- Central Nervous System Carcinoma
- Central Nervous System Embryonal Tumor
- Central Nervous System Neoplasms
- Central Nervous System Tumor
- Cervical Adenosquamous Carcinoma
- Cervical Cancer
- Cervical Intraepithelial Neoplasia
- Cervical Squamous Intraepithelial Neoplasia 2
- Checkpoint Kinase 2 Gene Mutation
- CHEK2 Mutation
- Chemotherapeutic Toxicity
- Chemotherapy-induced Thrombocytopenia
- Cholangiocarcinoma
- Chondrosarcoma
- Chordoma
- Choriocarcinoma
- Chromosomal Instability
- Chronic Lymphocytic Leukaemia
- Chronic Lymphocytic Leukemia
- Chronic Myeloid Leukemia
- Chronic Myelomonocytic Leukemia
- Circulating Tumor DNA
- Clear Cell Adenocarcinoma
- Clear Cell Carcinoma
- Clinically Node-Negative (cN0)
- CNS Metastases
- Collecting Duct Carcinoma
- Colon Cancer
- Colorectal Adenoma and Carcinoma 1
- Colorectal Cancer
- Colorectal (Colon or Rectal) Cancer
- Colorectal Serrated Adenocarcinoma
- Colorectal Tumor
- Corpus Uteri Cancer
- Craniopharyngioma
- Cutaneous Mucinous Carcinoma
- Cutaneous T-Cell Lymphoma
- Cyclin-Dependent Kinase 4
- Cyclin-Dependent Kinase 6
- Desmoid Tumor
- Desmoplastic Small Round Cell Tumors
- Detection of Cancer
- Diffuse Large B-Cell Lymphoma
- Digestive System Carcinoma
- Digestive System Neuroendocrine Neoplasm
- Digestive System Tumor
- Digital Papillary Adenocarcinoma
- DIPG
- DLL3-expressing Tumors
- DMMR Cancer
- DMMR Solid Malignant Tumor
- DNA Repair-Deficiency Disorders
- DNA Repair Disorder
- Driver Mutation
- Ductal Carcinoma
- Ductal Carcinoma in Situ (DCIS)
- Dysplasia
- Ectomesenchymoma
- EGFR Amplification
- EGFR Exon 19 Deletion
- EGFR Gene Mutation
- EGFR L858R
- EGFR P-Loop and Alpha C-Helix Compressing
- EGFR PACC
- EGFR Uncommon Mutations
- Embryonal Carcinoma
- Embryonal Tumor With Multilayered Rosettes
- End Stage Cancer
- Endocrine Gland Tumor
- Endocrine Mucin-Producing Sweat Gland Carcinoma
- Endocrine Tumor
- Endometrial Cancer
- Endometrial Serous Adenocarcinoma
- Ependymal Tumor
- Ependymoma
- Epidermal Growth Factor 2 Negative Carcinoma of Breast
- Epidermal Growth Factor 2 Positive Carcinoma of Breast
- Epidermal Growth Factor Receptor
- Epithelioid Sarcoma
- Erdheim-Chester Disease
- Erythroleukemia
- Erythroleukoplakia
- Erythroplakia
- Esophageal Cancer
- Esophageal Undifferentiated Carcinoma
- Esophagogastric Cancer
- Esophagus Cancer
- Esophagus Cancer, Recurrent
- Essential Thrombocythemia
- Estrogen Receptor Negative
- Ewing Sarcoma
- Excision Margin
- Extragonadal Embryonal Carcinoma
- Extraocular Sebaceous Carcinoma
- Extrapulmonary Neuroendocrine Cancer (epNEC)
- Extraskeletal Myxoid Chondrosarcoma
- Eye Cancer
- Fallopian Tube Cancer
- Fallopian Tube Endometrioid Tumor
- Fallopian Tube High Grade Serous Adenocarcinoma
- Familial Adenomatous Polyposis
- Fanconi Anemia
- Fatigue Related to Cancer Treatment
- Female Reproductive System Neoplasm
- FGF19 Gene Amplification
- FGF19 Gene Overexpression
- FGFR Gene Alteration
- FGFR Gene Amplification
- FGFR4 Gene Fusions
- FGFR4 Gene Mutation
- Fibrolamellar Carcinoma
- Fibromyxoid Tumor
- FIGO
- First Line Platinum Chemotherapy
- FMS-like Tyrosine Kinase-3 (FLT3) Mutations
- Folate Receptor-Alpha Positive
- Gallbladder Cancer
- Gallbladder Carcinoma
- Ganglioneuroblastoma
- Ganglioneuroma
- Gastric Adenocarcinoma
- Gastric Nec
- Gastric (Stomach) Cancer
- Gastric Undifferentiated Carcinoma
- Gastric/Upper Gastrointestinal Cancer
- Gastrinoma
- Gastroesophageal Junction Cancer
- Gastrointestinal Cancer
- Gastrointestinal Cancers - Anus
- Gastrointestinal Cancers - Colorectal
- Gastrointestinal Cancers - Liver
- Gastrointestinal Cancers - Small Intestine
- Gastrointestinal Cancers - Stomach
- Gastrointestinal Peritoneal Carcinomatosis
- Gastrointestinal Stromal Cancer
- Gastrointestinal Stromal Cell Tumors
- Gastrointestinal Stromal Neoplasm
- Gastrointestinal Stromal Tumor
- Genital Neoplasms
- Genitourinary Cancer
- Genitourinary System Carcinoma
- Genitourinary System Neoplasm
- GEP-NET
- Germ Cell Neoplasm
- Germ Cell Tumor
- Gestational Trophoblastic Tumor
- GI Cancers
- Giant Cell Carcinoma
- Glioblastoma
- Glioma
- Gliosarcoma
- Glucagonoma
- Gorlin Syndrome
- Gynecologic Cancer
- Gynecologic Neoplasm
- H3 K27M
- Head and Neck Cancer
- Head and Neck Squamous Cell Carcinoma
- Head and Neck Tumor
- Head Cancer
- Hematologic Cancer
- Hematologic Malignancy
- Hematologic Neoplasms
- Hematopoietic and Lymphatic System Neoplasm
- Hematopoietic and Lymphoid Cell Neoplasm
- Hematopoietic Neoplasm
- Hepatobiliary Cancer
- Hepatobiliary Neoplasm
- Hepatoblastoma
- Hepatocellular Cancer
- HER-2 Gene Amplification
- HER-2 Protein Overexpression
- HER2
- Hereditary Cancer
- HGG
- Hidradenocarcinoma
- Histiocytic and Dendritic Cell Neoplasm
- Histiocytic Disorders, Malignant
- Histiocytic Neoplasm
- Hodgkin's Lymphoma
- Homologous Recombination Deficiency
- Hormone Receptor Negative Tumor
- Hormone Receptor Positive Breast Cancer
- HSIL, High Grade Squamous Intraepithelial Lesion
- Hypopharyngeal Cancer
- IDH1 Gene Mutation
- IDH2 Gene Mutation
- IGF1R
- Immunoproliferative Disorders
- Immunotherapy
- Indolent Systemic Mastocytosis
- Infantile Fibrosarcoma
- INI1-negative Tumors
- Insulinoma
- Intestinal Neoplasms
- Intraductal Papillary Mucinous Neoplasm
- Invasive Ductal Carcinoma
- Islet Cell Carcinoma
- Juvenile Myelomonocytic Leukemia
- Kaposi's Sarcoma
- Kidney Cancer
- Kidney Medullary Carcinoma
- Kidney Neoplasm
- KMT2Ar
- KRAS Activating Mutation
- KRAS G12A
- KRAS G12C
- KRAS G12C Mutation
- KRAS G12D
- KRAS G12F
- KRAS G12R
- KRAS G12S
- KRAS G12V
- KRAS G13C
- KRAS G13D
- KRAS Gene Mutation
- KRAS Mutation-Related Tumors
- Lambert–Eaton Myasthenic Syndrome
- Langerhans Cell Histiocytosis
- Large Cell Lung Carcinoma
- Large Intestine Cancer
- Laryngeal Cancer
- Laryngeal Verrucous Carcinoma
- LCC
- Leiomyosarcoma
- Leptomeningeal Neoplasm
- Leukemia
- LGG
- Lip and Oral Cavity Cancer
- Lip and Oral Cavity Carcinoma
- Liposarcoma
- Liver Cancer
- Localized Osteosarcoma
- Locally Advanced
- Locally Advanced Malignant Solid Neoplasm
- Locally Advanced Salivary Gland Carcinoma
- Lung Adenosquamous Carcinoma
- Lung Cancer
- Lung Metastases
- Lung Neuroendocrine Neoplasm
- Lung Non-Small Cell Squamous Carcinoma
- Lung Sarcomatoid Carcinoma
- Lung Transplant
- Lung Tumor
- Lyme Disease
- Lymphatic Malformations
- Lymphatic System Neoplasm
- Lymphedema
- Lymphoid Malignancies
- Lymphoma
- Lymphoproliferative Disorders
- Lynch Syndrome
- Malignancies Multiple
- Malignancies
- Malignant Neoplasm
- Mammary Cancer
- Mammary Carcinoma
- Mantle Cell Lymphoma
- MAPK Pathway Gene Mutation
- Matched Targeted Therapy
- Mature B-Cell Malignancies
- MDM2 Gene Mutation
- Medulloblastoma
- MEK Mutation
- Melanocytic Neoplasm
- Merkel Cell Carcinoma
- Mesoblastic Nephroma
- MESOM
- Mesothelioma
- Metastases to Bone
- Metastases
- Metastasis From Malignant Tumor of Cervix
- Metastasis From Malignant Tumor of Liver
- Metastatic Castration-Resistant Prostate Cancer
- Metastatic Osteosarcoma
- Metastatic Tumor
- Microcystic Adnexal Carcinoma
- Microsatellite Instability
- Mismatch Repair Deficiency
- Mixed Cellularity Classic HL
- Mixed Müllerian Tumor
- MLL Rearrangement
- Mohs Micrographic Surgery
- MSI-H Cancer
- MSI-H Solid Malignant Tumor
- Mucinous Adenocarcinoma
- Mucinous Cystadenocarcinoma
- Multi-target Stool DNA
- Multiple Myeloma
- Mycosis Fungoides
- Myelodysplastic Syndrome
- Myelofibrosis
- Myeloma
- Myeloproliferative Disorders
- Myeloproliferative Neoplasms
- Myxofibrosarcoma
- Nasal Cavity Adenocarcinoma
- Nasal Cavity Carcinoma
- Nasopharyngeal Cancer
- Nasopharyngeal Undifferentiated Carcinoma
- NBN Gene Mutations
- Neck Cancer
- Neoadjuvant
- Neoplasms
- Neoplasm Metastasis
- Neoplasm of Bone
- Neoplasms, Glandular and Epithelial
- Nerve Sheath Neoplasm
- Nerve Sheath Tumor
- Neuroblastoma
- Neuroendocrine Cancer
- Neuroendocrine Carcinoma
- Neuroendocrine Neoplasm
- Neuroendocrine Tumor
- NF2 Gene Mutation
- Nodular Sclerosis Classic HL
- Non-Hodgkin Lymphoma
- Non-Small Cell Adenocarcinoma
- Non-Small Cell Lung Cancer
- Non-Small Lung Cell Cancer
- Non-urothelial Bladder
- Non-urothelial Upper Tract
- NPM1 Mutation
- NRAS G12C
- NRAS G12D
- NRAS G12R
- NRAS G12S
- NRAS G12V
- NRAS G13D
- NRAS G13R
- NRAS Gene Mutation
- NRAS Q61H
- NRAS Q61K
- NRAS Q61L
- NRAS Q61R
- NRG1 Fusion
- NTRK Family Gene Mutation
- NUT Carcinoma
- Ocular Melanoma
- Odontogenic Neoplasm
- Oligodendroglioma
- Oligometastatic Disease
- Oligometastatic Malignant Solid Neoplasm
- Oligoprogressive
- Oral Cancer
- Oral Cavity Cancer
- Oral Cavity Carcinoma
- Oral Verrucous Carcinoma
- Oropharyngeal Cancer
- Oropharyngeal Undifferentiated Carcinoma
- Oropharynx Cancer
- Osteosarcoma
- Ovarian Cancer
- Ovarian Clear Cell Carcinoma
- Ovarian Clear Cell Tumor
- Ovarian Embryonal Carcinoma
- Ovarian Endometrioid Tumor
- Ovarian Epithelial Carcinoma
- Ovarian Low Grade Serous Adenocarcinoma
- Ovarian Mucinous Cystadenocarcinoma
- Ovarian Seromucinous Carcinoma
- Ovarian Serous Adenocarcinoma
- Ovarian Serous Tumor
- Ovarian Tumor
- Ovarian Undifferentiated Carcinoma
- Ovary Cancer
- Ovary Neoplasm
- P53 Mutation
- Pain Cancer
- PALB2 Gene Mutation
- Pancreatic Acinar Cell Carcinoma
- Pancreatic Adenosquamous Carcinoma
- Pancreatic Cancer
- Pancreatic Ductal Adenocarcinoma
- Pancreatic Ductal Carcinoma
- Pancreatic Neoplasms
- Pancreatic NET
- Pancreatic Neuroendocrine Neoplasm
- Pancreatic Tumor
- Pancreatobiliary Carcinoma
- Papillary Adenocarcinoma
- Paranasal Sinus Adenocarcinoma
- Paranasal Sinus Carcinoma
- Paraproteinemias
- Parathyroid Gland Carcinoma
- PCPG
- PD-L1 Negative
- PD-L1 Positive
- PEComa
- Pelvic Neoplasm
- Penile Cancer
- Penile Carcinoma
- Peripheral Nerve Sheath Tumor
- Peripheral Nerve Sheath Tumors (MPNST)
- Peritoneal Cancer
- Peritoneal Carcinomatosis
- Peritoneal Cavity Cancer
- Peritoneal High Grade Serous Adenocarcinoma
- Peritoneal Low Grade Serous Adenocarcinoma
- Peritoneal Mesothelial Neoplasm
- Peritoneal Serous Adenocarcinoma
- Peritoneal Undifferentiated Carcinoma
- Peritoneum Cancer
- PI3K Gene Mutation
- PIK3CA Mutation
- Plasma Cell Dyscrasia
- Pleural Carcinomatosis
- Pleural Neoplasm
- Pleuropulmonary Blastoma
- Polycythemia Vera
- Porocarcinoma
- Post-essential Thrombocythemia Myelofibrosis
- Post-ET Myelofibrosis
- Post-PV MF
- Post-Transplant Lymphoproliferative Disease
- Posterior Fossa Ependymal Tumor
- Postneoadjuvant Therapy
- Preleukemia
- Primary Myelofibrosis
- Primitive Neuroectodermal Tumor
- Progesterone Receptor Negative
- Prostate Cancer
- Prostate Ductal Adenocarcinoma
- Prostate Intraductal Carcinoma
- Prostate Metastases
- Prostate Neuroendocrine Neoplasm
- PSA Progression
- Pseudomyxoma Peritonei
- PTEN Hamartoma Tumor Syndrome
- RAD51 Gene Mutation
- Radiotherapy
- RAF Gene Mutation
- Ras (Kras or Nras) Gene Mutation
- RAS Mutation
- RCC
- Rectal Cancer
- Rectal Tumor
- Recurrent Osteosarcoma
- Recurrent Tumor
- Refractory Osteosarcoma
- Renal Cell Carcinoma
- Renal Pelvis Cancer
- Renal Pelvis Carcinoma
- Resectable Skin Lymphoepithelial Carcinoma
- Residual Cancer
- Rhabdoid Tumor
- Rhabdomyosarcoma
- Richter Transformation
- Richter's Syndrome
- Richter's Transformation
- ROS1 Gene Mutation
- Salivary Gland Cancer
- Salivary Gland Carcinoma
- Sarcoma
- Secondary Myelofibrosis
- Secondary Osteosarcoma
- Sellar Tumor
- Seminal Vesicle Adenocarcinoma
- Seminoma
- Sentinel Lymph Node
- Serous Cystadenocarcinoma
- Sezary Disease
- Siewert Type 1 GEJ Cancer
- Signet Ring Cell Adenocarcinoma
- Sinonasal Cancer
- Skin Adnexal Carcinoma
- Skin Basosquamous Cell Carcinoma
- Skin Cancer/Melanoma
- Skin Keratoacanthoma
- Skin Lymphoepithelial Carcinoma
- Skull Base Neoplasms
- Small Cell Carcinoma
- Small Intestinal Adenocarcinoma
- Small Intestinal Carcinoma
- Small Intestine Cancer
- Small Intestine Cancer, Recurrent
- Small Lymphocytic Lymphoma
- SMARCA4-deficient Malignant Tumors
- SMARCA4-Deficient Tumor
- Smoldering Systemic Mastocytosis
- Soft Tissue Cancer
- Soft Tissue Neoplasm
- Soft Tissue Sarcoma
- Solid Carcinoma
- Solid Malignancies
- Solid Neoplasm
- Solid Tumor
- Somatic Mutation
- Somatostatinoma
- Sonodynamic Therapy
- Spinal Column Tumor
- Spinal Tumor Case
- Spindle Cell Neoplasm
- Spine Metastasis
- Spine Tumor
- Squamoid Eccrine Ductal Carcinoma
- Squamous Cell Carcinoma
- SST2-positive Neuroendocrine Neoplasms
- Stereotactic Body Radiation Therapy (SBRT)
- Stomach Cancer
- Stromal Neoplasm
- Survivorship
- Sweat Gland Carcinoma
- Sweat Gland Neoplasm
- Synovial Sarcoma
- Systemic Mastocytoses, Aggressive
- Systemic Mastocytoses, Indolent
- T Cell Lymphoma
- Teratoma
- Testicular Cancer
- Thoracic Cancer
- Thoracic Tumors
- Thymic Tumors
- Thymus Carcinoma
- Thymus Neoplasm
- Thymus Neuroendocrine Neoplasm
- Thyroid Cancer
- Tongue Carcinoma
- Tracheal Carcinoma
- Transitional Cell Carcinoma
- Treated With Radiation Therapy
- Trichilemmal Carcinoma
- Triple-Negative Breast Cancer
- Tumors
- Tumor Metastasis
- Tumor Neck
- Tumor of Breast
- Tumor Recurrence
- Unclassified Tumor, Malignant
- Unresectable Carcinoma
- Unresectable Gallbladder Carcinoma
- Unresectable Malignant Solid Neoplasm
- Unresectable Salivary Gland Carcinoma
- Unresectable Solid Neoplasm
- Unresectable Thymus Neuroendocrine Neoplasm
- Unresectable Vaginal Carcinoma
- Ureteral Cancer
- Urethral Adenocarcinoma
- Urethral Cancer
- Urinary Bladder Tumor
- Urogenital Neoplasms
- Urologic Cancer
- Urologic Neoplasms
- Uterine Cancer
- Uterine Neoplasms
- Vaginal Adenocarcinoma
- Vaginal Adenosquamous Carcinoma
- Vaginal Cancer
- Vaginal Carcinoma
- Vascular Tumor
- Viral Cancer
- Vulvar Cancer
- Vulvar Carcinoma
- Vulvar Neoplasms
- Waldenstrom Macroglobulinemia
- Warburg Effect
- Wilms Tumor
- WNT Pathway